Reversing the Paradigm for Atherosclerosis Therapy: The Potential of HDL Therapeutics

Author：

ISSN： 1537-1328

Source： Pharmaceutical Innovation, Vol.11, Iss.6, 2002-10, pp. : 21-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HDL and Inflammation in Atherosclerosis

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : 51-57

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Stress, HDL and Atherosclerosis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-01 ,pp. : 158-165

Bentham Science Publishers

Access to resources Recommend Favorite

Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy

By Jukema J Wouter van der Hoorn José WA

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 459-468

Informa Healthcare

Access to resources Recommend Favorite

Reconstituted HDL fails to ERASE atherosclerosis

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Reversing Anticoagulant Therapy

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 143-149

Bentham Science Publishers

Access to resources Recommend Favorite